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The ActVA-ActVB system from 
Streptomyces coelicolor is a two-component 
flavin-dependent monooxygenase involved 
in the antibiotic actinorhodin biosynthesis. 
ActVB is a NADH:flavin oxidoreductase 
that provides a reduced FMN to ActVA, the 
monooxygenase that catalyzes the 
hydroxylation of dihydrokalafungin, the 
precursor of actinorhodin. In this work, 
using stopped-flow spectrophotometry, we 
investigated the mechanism of 
hydroxylation of dihydrokalafungin 
catalyzed by ActVA and that of the reduced 
FMN transfer from ActVB to ActVA. Our 
results show that the hydroxylation 
mechanism proceeds with the participation 
of two different reaction intermediates in 
ActVA active site. First, a C(4a)-FMN-
hydroperoxide species is formed after 
binding of reduced FMN to the 
monooxygenase and reaction with O2. This 
intermediate hydroxylates the substrate and 
is transformed to a second reaction 
intermediate, a C(4a)-FMN-hydroxy 
species. In addition, we demonstrate that 
reduced FMN can be transferred efficiently 
from the reductase to the monooxygenase 
without involving any protein-protein 
complexes. The rate of transfer of reduced 
FMN from ActVB to ActVA was found to be 
controlled by the release of NAD+ from 
ActVB and was strongly affected by NAD+ 
concentration, with an IC50 of 40 µM. This 
control of reduced FMN transfer by NAD+ 
was associated with the formation of a 
strong charge-transfer complex between 
NAD+ and reduced FMN in the active site of 
ActVB. These results suggest that in 
Streptomyces coelicolor, the reductase 
component ActVB can act as a regulatory 
component of the monooxygenase activity 
by controlling the transfer of reduced FMN 
to the monooxygenase. 
 
The flavin dependent monooxygenases are 
important enzymes that are involved in a wide 
variety of biological reactions. One of their 
fundamental functions uses their reduced 
flavins to activate molecular oxygen by 
generating flavin-hydroperoxide intermediates, 
the reactive species that oxygenate the 
substrate. Two different classes of flavin-
dependent monooxygenases have been 
described. The first class comprises the well-
known single-component flavoprotein 
monooxygenases, in which within a single 
polypeptide chain, the flavin cofactor is 
reduced by NAD(P)H and reacts with O2 to 
generate the flavin-hydroperoxide species. 
Some of these flavoproteins have been 
investigated in great detail, p-hydroxybenzoate 
hydroxylase being the prototype of this class of 
flavoprotein monooxygenase (1). More 
recently, several two-component flavin-
dependent monooxygenases, present in 
prokaryotic cells and involved in a broad range 
of oxygenation reactions, have been reported. 
These systems use two different proteins, a 
reductase for reducing the flavin and an 
oxygenase for binding the reduced flavin and 
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catalyzing the reaction with O2. Examples of 
two-component monooxygenases that use 
reduced FAD (FADred) as a cofactor are 4-
hydroxyphenylacetate monooxygenase (HpaB) 
from Escherichia coli (2), phenol hydroxylase 
(PheA1) from Bacillus 
thermoglucosidaflurescens (3) and styrene 
monooxygenase (StyA) from Pseudomonas 
fluorescens (4, 5). Two-component flavin-
dependent monooxygenases that use reduced 
FMN (FMNred) include enzymes involved in 
the biosynthesis of the antibiotic pristinamycin 
in Streptomyces pristinaespiralis (6, 7), in the 
utilization of sulfur from aliphatic sulfonates in 
Escherichia coli (8) and in the desulfurization 
of fossil fuels by Rhodococcus species (9), as 
well as the hydroxylation of 4-
hydroxyphenylacetate in Acinetobacter 
baumannii (10). We have been investigating 
the mechanism of the FMN-dependent two-
component enzyme system, ActVA-ActVB, 
which participates in the last steps of the 
biosynthesis of the antibiotic actinorhodin in 
Streptomyces coelicolor (11-13) (Scheme 1). 
The first enzyme of the two-component 
flavin-dependent oxygenases is a 
NAD(P)H:flavin oxidoreductase that catalyzes 
the reduction of free oxidized flavins (FAD 
and/or FMN) by the reduced pyridine 
nucleotides, NADPH or NADH (3, 14-16). 
The second enzyme is an oxygenase that binds 
the resulting free reduced flavin and promotes 
its reaction with O2 to hydroxylate the 
substrate (2, 3, 5-10, 17). Therefore, in contrast 
to the single-component flavin hydroxylases, 
the two-component systems catalyze the 
reduction of the flavin and the hydroxylation 
of the substrate on separate polypeptides. In 
the biosynthesis of actinorhodin the 
hydroxylase system consists of the reductase, 
ActVB, and the oxygenase, ActVA (14,15,17). 
There is now general agreement that the 
hydroxylation steps of flavin-dependent 
hydroxylases proceed through the reaction of 
the reduced flavin with molecular oxygen to 
generate a flavin C(4a)-hydroperoxide 
intermediate (18). This is followed by the 
transfer of an oxygen atom from the peroxide 
to the substrate.  
Catalysis by the two-component flavin-
dependent monooxygenases requires that the 
reduced flavin be transferred from the 
reductase to the monooxygenase without being 
oxidized by molecular O2. This would appear 
to be a very challenging process because free 
reduced flavin becomes oxidized quite rapidly 
in the presence of O2. Such an oxidation must 
be avoided or the reduction of the flavin and 
the ensuing hydroxylation reaction would 
effectively be uncoupled and, instead, 
NAD(P)H would be consumed to produce 
H2O2 and superoxide. We have previously 
demonstrated that with the ActVA-ActVB 
system from S. coelicolor the transfer of 
FMNred from the reductase to the oxygenase is 
thermodynamically favorable (17). Indeed the 
monooxygenase ActVA binds FMNred with a 
Kd value of 0.39 µM and FMNox with a Kd 
value of about 20 µM, while the reductase 
ActVB binds FMNox more tightly than FMNred. 
There is also no evidence for specific binding 
interactions between the two components that 
might facilitate a channeling mechanism 
allowing the flavin to travel from one protein 
to another within a protein complex. These 
data suggest that in spite of the drawbacks 
associated with the simultaneous presence of 
free FMNred and O2, FMNred is probably 
transferred between the two components by 
diffusion and rapid binding to the oxygenase 
during the hydroxylation reaction.  
In this work, we have determined that 
FMNred can be transferred very efficiently from 
the reductase to the monooxygenase without 
the participation of any protein-protein 
complexes. In addition, our data show that in 
the S. coelicolor system the rate of transfer of 
FMNred from the reductase, ActVB to the 
hydroxylase, ActVA, is controlled by the 
release of NAD+ from ActVB, and that the 
concentration of NAD+ strongly affects this 
rate. This is manifest by the formation of a 
strong charge-transfer complex between NAD+ 
and FMNred in the active site of ActVB. 
 
EXPERIMENTAL PROCEDURES 
Materials. NAD+, NADH, and FAD were 
from Sigma. FMN was prepared by conversion 
of FAD to FMN with snake venom from 
Crotalus adamanteus (19). DCPIP and 
menadione were from Sigma. 5-Deazaflavin 
(5-deaza-5-carba-riboflavin) was a gift from 
Dr. Philippe Simon (Grenoble, France). 
Enantiopure (+)-Kalafungin was synthesized 
by Dr. Rodney Fernandes and provided by 
Prof. Dr. Reinhard. Brückner (Freiburg, 
Germany) (20). DHK (dihydrokalafungin), the 
non-lactonic analogue of (+)-kalafungin, was 
obtained from the reductive treatment of (+)-
kalafungin by NaBH4 as described in (21). A 
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solution containing 40 µM (+)-kalafungin in 
anaerobic 50 mM Tris-HCl buffer, pH 7.4, was 
mixed with ~7 equivalents of NaBH4. The 
reaction was allowed to proceed for a few 
seconds under anaerobic conditions and the 
mixture was then opened to air. The formation 
of DHK was verified by UV-visible 
spectrophotometry and LC-MS/MS. Both 
techniques showed that (+)-kalafungin was 
efficiently transformed to DHK with a yield of 
~100 % (data not shown). HPAH-C2 from A. 
baumanii was provided by Dr. Jeerus 
Sucharitakul (Mahidol University, Thailand). 
Recombinant ActVA-Orf5 and His-tagged 
ActVB from S. coelicolor were overexpressed 
in E. coli and purified as described previously 
(14, 17).  
Anaerobic procedures and rapid reaction 
experiments. All reactions were performed in 
50 mM Tris-HCl buffer, pH 7.4, at 4°C. 
Solutions were made anaerobic in glass 
tonometers by ~20 cycles of vacuum and 
equilibration with Ar2 gas that was depleted 
from oxygen contamination with an Oxiclear 
oxygen removal column (Labclear) as 
described previously (22). To minimize 
oxygen contamination of reaction mixtures due 
to diffusion through valves, etc, all anaerobic 
solutions contained an oxygen-scrubbing 
solution consisting in 12.5 to 25 µM 
protocatechuate (PCA, final concentrations) 
and ~0.06 units/ml of protocatechuate 
dioxygenase (PCD, final concentration). This 
mixture has been shown to maintain anaerobic 
conditions efficiently (23). 
Rapid kinetics reactions were performed 
with a Hi-Tech Scientific stopped-flow Model 
SF-61DX instrument operating either in single 
or in double mixing mode, and using either a 
diode array spectrophotometer or a 
photomultiplier detector. Kinetic traces were 
analysed and fitted with KinetAsyst 3 software 
(Hi-Tech Scientific, Salisbury, UK). Before 
each experiment, the stopped-flow instrument 
flow system was made anaerobic by incubating 
the flow system overnight with an oxygen 
scrubbing solution consisting of 100 mM PCA 
and 0.06 units/ml  PCD in potassium phosphate 
buffer, pH 7. 
Reaction of ActVA·FMNred with O2 in the 
presence or in the absence of the 
pyronaphthoquinone substrate DHKred. A 
solution containing ActVA (50 µM), FMNox 
(20 µM), deazaflavin (60 nM), EDTA (10 
mM) and catalase (50 nM) in 50 mM Tris-HCl 
buffer, pH 7.4, was made anaerobic in a glass 
tonometer as described above. FMNox was then 
photoreduced for 5 to 10 sec using a 
commercial 1000 W tungsten-halogen lamp 
placed ~10 cm away from the solution. The 
redox status of FMN was monitored by UV-
visible spectrophotometry. When experiments 
were performed in the presence of DHK, the 
same reaction mixture as indicated above was 
used, but included the presence of 80 µM 
DHK. Both FMNox and oxidized DHK 
(DHKox) were photoreduced together by the 
procedure described above. This solution was 
then mixed in the stopped-flow instrument 
with an equal volume of a solution containing 
various concentrations of oxygen, and the 
reaction was followed spectrophotometrically 
at various wavelengths, or by 
spectrofluorimetry with excitation at 390 nm 
and emission at wavelengths > 530 nm. 
Oxygenated solutions were prepared by 
equilibrating 50 mM Tris-HCl buffer for 30 
min with air (21% oxygen) or with certified 
oxygen/nitrogen gas mixtures (5, 10, 50, 100 
% oxygen). 
Investigation of the kinetics of FMNred 
transfer. To study the transfer of FMNred from 
ActVB to the monooxygenase (ActVA or 
HPAH-C2), the ActVB·FMNred complex was 
prepared. A solution containing ActVB (85 
µM) and FMNox (20 µM) in Tris-HCl buffer, 
pH 7.4, in a glass tonometer equipped with a 
cuvette was made anaerobic as described 
above. The excess ActVB was to assure that 
most of the FMN was bound. The complex 
was then reduced by titration with an anaerobic 
solution of NADH delivered by a gastight 
Hamilton syringe connected to the tonometer 
via an Airless Ware fitting. Approximately 20 
µM of NADH was sufficient to fully reduce 
the ActVB·FMN complex. This complex was 
then mixed in the stopped-flow instrument 
with an equal volume of Tris-HCl buffer 
containing ActVA (45 µM) and O2 (600 µM), 
HPAH-C2 from A. baumanii (45 µM) and 
O2 (600 µM), oxidized DCPIP (2,6-
dichlorophenolindophenol, 20 µM), or 
oxidized menadione (40 µM). The 
concentrations given are those in the syringes 
before mixing. The inhibition of FMNred 
transfer from ActVB to HPAH-C2 by NAD+ 
was investigated by a double mixing stopped-
flow technique. The ActVB·FMNred·NAD+ 
complex prepared as described above (235, 40 
 4 
and 40 µM of each component respectively), 
was first mixed into an aging chamber with a 
solution containing various concentrations of 
NAD+ (from 0 to 5 mM). After a 5 s delay to 
assure that the binding of NAD+ had come to 
equilibrium, the solution from the first mix was 
mixed with an equal volume of 50 mM Tris-
HCl buffer containing HPAH-C2 (50 µM) and 
O2 (255 µM), and the FMNred transfer to 
HPAH-C2 was followed 
spectrophotometrically at 386 and 700 nm to 
observe the formation of the C(4a)-FMN-OOH 
intermediate and the disappearance of the 
FMNred–to–NAD+ charge-transfer complex. 
 
RESULTS 
 
Reaction of ActVA-FMNred with O2 in the 
absence of the pyronaphthoquinone substrate. 
Formation and decay of the C(4a)-FMN-OOH 
intermediate. It has been previously shown that 
ActVA is able to stabilize a C(4a)-FMN-OOH 
species within its active site, but the kinetics of 
its formation and decay were not determined 
(17, 24). Here, we have investigated the 
kinetics of the formation and decay of the 
C(4a)-FMN-OOH intermediate by stopped-
flow spectrophotometry at 4°C, as described in 
Materials and Methods. An anaerobic solution 
of FMNred (20 µM), containing an excess of 
ActVA (50 µM) to promote full complex 
formation (Kd FMNred = 0.39 µM, (17)), was 
mixed with equal volumes of Tris-HCl buffer 
solution containing various concentrations of 
O2. The reaction was monitored by UV-visible 
spectrophotometry. As shown in Fig. 1A (thick 
line) the first spectrum recorded at 5 s ([O2] = 
595 µM after mixing) has a main absorption 
band at 386 nm. This spectrum is characteristic 
of a C(4a)-FMN-OOH species, such as those 
found in other single- and two-component 
flavin-dependent hydroxylases, including 4-
hydroxyphenylacetate 3-hydroxylase (HPAH-
C2) from A. baumannii (22) and p-
hydroxybenzoate hydroxylase (PHBH) from 
Pseudomonas aeruginosa (25, 26). Reaction 
traces monitored at 386 nm were fit to a single 
exponential model and the rate constants for 
formation of the absorbing species were found 
to be proportional to the O2 concentration (Fig. 
1B). The linear plot of kobs at 386 nm versus 
oxygen concentration yielded a second-order 
rate constant of k = 2.97 ± 0.06 x 104 M-1 s-1 
(Fig. 1C). These data are consistent with a 
bimolecular reaction between the reduced 
flavin bound to ActVA and oxygen to form the 
C(4a)-FMN-OOH intermediate.  
The C(4a)-FMN-OOH then slowly 
converted to FMNox with a half-life of about 
1400 s and was complete by ~1 hour, as seen 
from the appearance of the two characteristic 
bands of the oxidized flavin at 370 and 445 nm 
(Fig. 1A). The absorbance changes at 445 nm 
(Fig. 1B) were found to be independent of 
oxygen concentration. These data, which are 
consistent with our previous results from 
experiments at 25 °C, clearly show that ActVA 
strongly stabilizes the C(4a)-FMN-OOH 
intermediate (17, 24). At the end of this slow 
decay of the intermediate, 10 µM FMNox was 
detected (ε445nm = 13 mM-1 cm-1), indicating 
that all of the initial FMNred was quantitatively 
oxidized to FMNox by O2. An ε value at 386 
nm of 9.6 mM-1 cm-1 for the C(4a)-FMN-OOH 
species could then be calculated.  
Interestingly, when free FMNred was mixed 
with an air-saturated ActVA solution in the 
stopped-flow apparatus, kinetic traces were the 
same as those obtained when a preformed 
ActVA·FMNred complex was mixed with the 
same concentration of oxygen (data not 
shown). This implies that almost no 
spontaneous oxidation of free FMNred by O2 
occurred, even though autoxidation of free 
FMNred by O2 is a reasonably fast process. For 
example, 40 µM FMNred is oxidized by 240 
µM O2, final concentration, in an autocatalytic 
reaction with a t1/2 ~0.5 s (27, unpublished 
data), and no detectable C(4a)-FMN-OOH 
species is produced (28). This result implies 
that binding of FMNred to ActVA preceding the 
formation of the C(4a)-FMN-OOH species is 
fast and precludes any significant oxidation of 
free FMNred by oxygen. These results explain 
and are in full agreement with our previous 
steady-state kinetics experiments (24). 
Reaction of ActVA-FMNred with O2 and 
pyronaphthohydroquinone substrate. The 
reaction of O2 with FMNred bound to ActVA in 
the presence of its substrate, reduced 
dihydrokalafungin (DHKred), was investigated 
by stopped-flow spectrophotometry. An 
anaerobic solution containing 80 µM of 
DHKred, 20 µM of FMNred and an excess of 
ActVA (50 µM, to ensure that most of the 
FMNred was in complex with ActVA) was 
mixed with equal volumes of oxygenated Tris-
HCl buffer solution containing various 
amounts of O2. In Figure 2, the reported data 
were observed with a final O2 concentration of 
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595 µM. The reaction was followed at : (i) 365 
nm, a wavelength that is useful for monitoring 
the formation of the C(4a)-FMN-OOH 
intermediate species (22, 29, 30) and at which 
DHKred contributes to the absorbance 
minimally; (ii) 445 nm to monitor the 
formation of FMNox; (iii) 520 nm to monitor 
the formation of the hydroxylated DHKox 
product (DHKox-OH) (24). In addition, 
fluorescence emission at 530 nm (excitation at 
390 nm) was recorded in order to follow the 
formation of C(4a)-FMN-OH (hydroxy-FMN) 
and FMNox species. For many flavin-
dependent hydroxylases, the C(4a)-FMN-OOH 
intermediate does not exhibit significant 
fluorescence emission upon excitation at 390 
nm, whereas the C(4a)-FMN-OH species is 
often highly fluorescent (22, 29, 31). The 
absorbance values at the above mentioned 
wavelengths are plotted as a function of time in 
Fig. 2A. These data indicate that the reaction 
proceeds through at least four successive 
phases (Fig. 2A, Table 1). Each trace could be 
fitted by the sum of four exponential processes 
using a single set of rate constants for data at 
all wavelenghts. 
The rate constant k1 for phase 1 was 
directly dependent on O2 concentration (data 
not shown), indicating a bimolecular reaction 
with O2. No FMNox (445 nm trace) and almost 
no C(4a)-FMN-OH (fluorescence at 530 nm) 
were observed during this first phase. Thus, the 
bimolecular rate constant (3.96 ± 0.05 x 104 M-
1
 s-1) determined from the increase in 
absorbance at 365 nm is clearly associated 
with the formation of the C(4a)-FMN-OOH 
intermediate. This rate constant is only slightly 
different from that determined in the absence 
of the DHKred substrate (Fig. 1C, 2.97 ± 0.06 x 
104 M-1 s-1). In the subsequent phases, k2, k3, 
and k4, were found to be independent of O2 
concentration (data not shown), indicating that 
they did not involve direct reactions with O2. 
In phase 2, the appearance of fluorescence 
at 530 nm (with excitation at 390 nm) reached 
a maximum at ~2 sec reaction time, with a rate 
constant of 1.48 ± 0.15 s-1. Although there is 
only a small decrease in absorbance at 365 nm 
in this phase, the fluorescence data clearly 
reflect the hydroxylation reaction. Therefore, 
the above data are consistent with the 
formation of the C(4a)-FMN-OH intermediate 
species in phase 2, implying that hydroxylation 
of the DHKred substrate occurred during that 
phase. The trace at 520 nm does not show any 
increase in absorbance during this phase as 
might be expected for DHKox-OH. The 
immediate product is therefore most likely 
DHKred-OH, which has very little absorbance 
or fluorescence (unpublished data), and is not 
expected to contribute significantly to the 
absorption and fluorescence data during phase 
2.  
Phase 3 is best indicated by the strong 
increase in absorbance at 445 nm characterized 
by a rate constant of  0.16 ± 0.02 s-1. This was 
due to formation of FMNox, which is expected 
to arise from dehydration of the C(4a)-FMN-
OH intermediate. The small decrease of 
fluorescence with an identical rate constant 
(0.16 ± 0.02 s-1) likely reflects the smaller 
fluorescence quantum efficiency of FMNox 
(with excitation at 390 nm) as compared to that 
of C(4a)-FMN-OH, as has been shown for 
other flavin-dependent hydroxylases (29, 31). 
Finally, phase 4 was mainly characterized 
by a slow increase of absorbance at 520 and 
450 nm (0.013 ± 0.002 s-1), which most likely 
represents the oxidation by O2 of the 
hydroquinone, DHKred-OH, into the quinone, 
DHKox-OH. This conclusion was also 
consistent with the spectrum recorded 200 s 
after mixing (Fig. 2B) that has an additional 
band extending to 600 nm. This spectrum is 
similar to that of a mixture of ~10 µM FMNox 
and ~10 µM DHKox-OH; the latter spectrum 
was presented in our previous work (24). 
Oxidation of hydroquinones and their 
derivatives such as DHKred by O2 appears to 
proceed through an autocatalytic mechanism 
with phases that are only partially dependent 
on the concentration of O2 (28, 32, 33). This is 
also the case for the reaction of O2 with 
DHKred, which becomes oxidized in an 
autocatalytic process with very little O2-
dependence (data not shown).  
The kinetic path of hydroxylation of 
DHKred catalyzed by ActVA is summarized in 
Scheme 2. One interesting feature of this 
reaction is that the formation of the C(4a)-
FMN-OOH intermediate, which in the 
presence of O2 forms quickly after FMNred is 
transferred to the monooxygenase, has very 
little dependence on the presence of the 
DHKred substrate. This indicates that the 
substrate may bind after the hydroperoxide 
intermediate is formed, as observed with 
HPAH-C2 (22), cyclohexanone 
monooxygenase (34), and microsomal flavin 
monooxygenase (35). 
 6 
FMNred transfer from ActVB to ActVA. Our 
previous investigations have shown that 
transfer of FMNred from the reductase ActVB 
to the monooxygenase ActVA is 
thermodynamically favorable (17). To study 
the kinetics of this transfer reaction, we took 
advantage of the UV-visible signature of the 
ActVBFMNredNAD+ complex, which has a 
broad charge-transfer (C–T) band between 550 
and 800 nm, as well as the formation of the 
C(a)-FMN-OOH intermediate that can be 
monitored at 380 nm. The C–T band originates 
from the interaction between NAD+ and 
FMNred in the ActVB active site (14). Our 
previous studies showed that, under anaerobic 
conditions, the addition of 1 equivalent of 
ActVA to the ActVBFMNredNAD+ complex 
resulted in total disappearance of the C-T band, 
implying that FMNred was transferred from 
ActVB to ActVA (17). 
In Fig. 3, an ActVB·FMNred·NAD+ 
complex (85, 20, and 20 µM, of each 
component, respectively) was anaerobically 
prepared by adding one equivalent of NADH 
to FMNox in the presence of ActVB. Then, the 
complex was mixed at 4°C with an equal 
volume of solution containing 45 µM ActVA 
and 600 µM O2 in a stopped-flow 
spectrophotometer. The UV-visible difference 
spectra (spectra at various times minus the 
initial spectrum of the ActVB·FMNred·NAD+ 
complex; this mode of display makes it easier 
to view the overall changes) were recorded as a 
function of time from 7 to 150 ms after mixing. 
Addition of the aerobic solution of ActVA to 
the anaerobic solution containing 
ActVB·FMNred·NAD+ resulted in total 
disappearance of the broad C–T band within 
~1 s, shown in Fig. 3A by the loss of 
absorbance between 440 and 700 nm. 
Simultaneously, an absorbance band centered 
at ~386 nm appeared, due to formation of the 
C(4a)-FMN-OOH species. The presence of an 
isobestic point at about 435 nm indicated an 
apparent direct conversion of the 
ActVB·FMNred·NAD+ complex to the C(4a)-
FMN-OOH-ActVA complex.  
Fig. 3B shows the kinetics of the 
absorbance changes at 386 nm (formation of 
C(4a)-FMN-OOH) and at 700 nm 
(disappearance of the C–T complex 
ActVB·NAD+·FMNred). Both traces could be 
fitted to a single exponential model with 
almost identical rate constants (k386nm = 4.6 ± 
0.1 s-1 and k700nm = 5.0 ± 0.4 s-1). It can be 
noted that this rate constant is smaller than that 
for the formation of the C(4a)-FMN-
OOH·ActVA complex from the reaction of 
free FMNred with O2 in the presence of ActVA 
(k386nm = 10.6 ± 0.1 s-1 for the reaction of 10 
µM free FMNred mixed with 22.5 µM ActVA 
and 300 µM O2 final concentrations, Fig. 1 and 
data not shown). Although these results 
suggest that under the experimental conditions 
of Fig. 3 formation of the C(4a)-FMN-OOH 
intermediate is rate-limited by the release of 
FMNred from ActVB, the relatively small 
difference in rates of these two processes 
tempers confidence in this conclusion. In order 
to further clarify the kinetics of dissociation of 
FMNred from ActVB, we performed the 
experiments described below. 
The HPAH-C2 monooxygenase from A. 
baumanii is part of a two-component FMN-
dependent monooxygenase similar to ActVA. 
Recently, it has been shown that under similar 
conditions to those used for ActVA in the 
experiment shown in Fig. 1, HPAH-C2 
monooxygenase binds free FMNred and reacts 
with O2 to form a C(4a)-FMN-OOH adduct 
very rapidly. The rate constant for binding 
FMNred to HPAH-C2 has been estimated to be 
> 107 M-1 s-1 and the ensuing reaction with O2 
occurs with a second-order rate constant of 1.1 
106 M-1 s-1 (22). Thus, if HPAH-C2 is reacted 
with free FMNred in the presence of 300 µM 
O2, the formation of the C(4a)-FMN-OOH 
intermediate will occur with a rate constant of 
~330 s-1, a value about 30 times greater than 
that reported for ActVA. Substitution of 
HPAH-C2 for ActVA in an experiment such as 
that in Fig. 3 would clearly distinguish whether 
the release of FMNred from ActVB is rate 
limiting. The experiment shown in Fig. 3 was 
repeated in the presence of HPAH-C2 
monooxygenase (25 µM, final concentration) 
in place of ActVA. As reported for the 
experiment with ActVA (Fig. 3), the 
ActVB·FMNred·NAD+ complex disappeared in 
parallel with the formation of the C(4a)-FMN-
OOH intermediate (data not shown). The 
kinetics of the absorbance changes at 386 nm 
(formation of the C(4a)-FMN-OOH species) 
and at 700 nm (disappearance of the C–T 
complex ActVB·NAD+·FMNred) could be fitted 
to a single exponential model, with rate 
constants (Table 2, k386nm = 4.7 ± 0.1 s-1 and 
k700nm = 3.8 ± 0.1 s-1) nearly identical to those 
obtained with ActVA (Table 2). These data are 
consistent with the limiting step for the transfer 
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of FMNred from ActVB to the monooxygenase 
component being the release of FMNred from 
the ActVB·NAD+·FMNred complex. 
Menadione and DCPIP are two redox dyes 
known to react very rapidly with reduced free 
flavin (36). When free FMNred is mixed with 
two equivalents of either one of these oxidized 
dyes, the FMNred becomes nearly fully 
oxidized during the dead time of the stopped-
flow experiment (implying that kox > 300 s-1, 
Table 2). However, when 
ActVB·FMNred·NAD+ was mixed with either 
DCPIP or menadione under anaerobic 
conditions, the FMNred was oxidized with rate 
constants of 6.2 ± 0.1 s-1 and 6.1 ± 0.1 s-1 for 
DCPIP and menadione, respectively (Table 2). 
In addition, the C–T complex (measured at 700 
nm) disappeared with rate constants (6.5 ± 0.1 
s-1 and 6.3 ± 0.1 s-1 for DCPIP and menadione 
respectively, Table 2). These rate constants are 
more than 50-fold smaller than those obtained 
when free FMNred reacted with these dyes 
(Table 2). As shown in Table 2, the rates of 
disruption of the charge-transfer complex 
obtained in the presence of the 
monooxygenases ActVA or HPAH-C2 and 
with the two dyes were almost identical. These 
results suggest that the rate of oxidation of the 
ActVB·NAD+·FMNred complex by the dyes as 
well as by the oxygenases is likely to be 
primarily limited by the release of FMNred 
from the complex. The slightly greater rates 
obtained with the dyes compared to those 
obtained with the two oxygenases can be 
explained by the dyes reacting with the FMNred 
before it is fully released from ActVB, whereas 
the C(4a)-FMN-OOH species can only form 
after FMNred is completely released and 
transferred to the oxygenases. 
Altogether, these data demonstrate that the 
formation of the C(4a)-FMN-OOH 
intermediate with the monooxygenases ActVA 
and HPAH-C2 is limited by the release of 
FMNred from the ActVB·NAD+·FMNred 
complex followed by its transfer to the 
monooxygenase. 
Inhibition of FMNred transfer by NAD+. 
Previous steady-state kinetics studies had 
shown that during the ActVB-catalyzed 
reaction (FMNox + NADH → FMNred + NAD+) 
the release of the NAD+ product occurs before 
that of FMNred (14). We tested whether the 
presence of NAD+ influences the transfer of 
FMNred from the ActVB·NAD+·FMNred 
complex to the monooxygenase by carrying 
out experiments similar to those described in 
the previous section with various 
concentrations of NAD+. In these experiments 
HPAH-C2 was used in place of ActVA 
because, as mentioned earlier, HPAH-C2 forms 
C(4a)-FMN-OOH very rapidly (22). Therefore, 
under these conditions, the formation of the 
C(4a)-FMN-OOH species provides a 
convenient and reliable coupled assay for 
monitoring the release of FMNred from ActVB. 
As shown in Fig. 4, the 
ActVBFMNredNAD+ complex (235, 40, and 
40 µM of the respective components), was 
anaerobically mixed with equal volumes of 
solutions containing various amounts of 
NAD+. After 5 s (to allow the NAD+ binding to 
come to equilibrium), this solution was mixed 
with an equal volume of an aerobic solution of 
HPAH-C2 (50 µM HPAH-C2 and 255 µM O2), 
and the absorbance values at 386 and 700 nm 
of the final mixture were followed as a 
function of time (Figs. 4A and 4B 
respectively). Addition of increasing amounts 
of NAD+ resulted in decreases of the rates of 
both the loss of the C–T complex (700 nm) and 
the formation of C(4a)-FMN-OOH (386 nm). 
For a given NAD+ concentration, traces at both 
386 and 700 nm could be fitted with a single 
exponential function with almost identical rate 
constants (Figs. 4A and 4B). As shown in Fig. 
4C, a plot of the rate constants obtained from 
the traces at 386 and 700 nm versus NAD+ 
concentration indicated that the presence of an 
excess of NAD+ could totally inhibit the 
transfer of FMNred from ActVB to HPAH-C2 
as well as the formation of the C(4a)-FMN-
OOH species. The IC50 concentration for 
inhibition by NAD+ was determined to be ~40 
µM.  
 
DISCUSSION 
 
In this work, we have carried out a detailed 
kinetic study of the reaction of the two-
component FMN-dependent monooxygenase, 
ActVA-ActVB from Streptomyces coelicolor, 
by stopped-flow spectrophotometric methods 
in order to test our earlier propositions on the 
reaction mechanism of ActVA-ActVB system 
(17, 24) and to gain insights into its 
mechanism of regulation. Recent 
characterization of several members of the 
two-component flavin-dependent 
monooxygenase family has revealed 
similarities to but also some specific 
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differences from the well-studied single 
component flavoprotein monooxygenase 
family, such as p-hydroxybenzoate 
hydroxylase. In both types of systems, the 
monooxygenase activates the oxygen molecule 
by forming a C(4a)-flavin hydroperoxide 
intermediate that delivers an oxygen atom to 
the substrate. In contrast to the single 
component hydroxylases, the reduction of the 
flavin in the two-component flavin-dependent 
monooxygenase systems is catalyzed by a 
separate NADH oxidoreductase and the 
resultant reduced flavin must then be delivered 
to the oxygenase. Thus, the mechanism by 
which the reduced flavin cofactor is transferred 
from the reductase to the monooxygenase in 
the presence of O2 represents one of the most 
challenging aspects of these systems. Here we 
have presented several experiments that 
elucidate the essential features of the 
mechanism of transfer of FMNred between 
ActVB and ActVA. Compared with the few 
studies recently published on other two-
component FMN-dependent monooxygenase 
systems, our results highlight a unique 
property of the ActVA-ActVB system, namely 
that the overall hydroxylase reaction is 
partially limited by the release of FMNred from 
the reductase, and this release is regulated by 
the dissociation rate of the charge transfer 
complex between NAD+ and FMNred. Large 
concentrations of NAD+, a product of the 
flavin reductase reaction, can greatly reduce 
the rate of FMNred release. Moreover, we show 
that no complexes between ActVB and ActVA 
are required for efficient transfer of FMNred 
between the two. 
At first, we studied the monooxygenase-
dependent reaction in the absence of the 
reductase component ActVB and under 
conditions where the ActVA·FMNred·DHKred 
complex was formed before it reacts with O2. 
We showed that the hydroxylation mechanism 
proceeds with the participation of two different 
reaction intermediates, a C(4a)-FMN-OOH 
that precedes, and a C(4a)-FMN-OH species 
that accompanies the formation of the reaction 
product, DHKred-OH (Fig. 2). The C(4a)-FMN-
OOH intermediate, characterized by a typical 
single absorbance band centered at 386 nm, 
results from the bimolecular reaction of the 
ActVA·FMNred complex with O2. This step 
occurs with a rate constant of ~4 x 104 M-1 s-1, 
essentially independent of the presence of the 
DHKred substrate. We note that in the 
monooxygenase HPAH-C2 component from A 
baumannii, when C2 in complex with FMNred 
and its substrate, 4-hydroxyphenylacetate (at 2 
mM), is mixed with O2, the rate of formation 
of the C(4a)-FMN-OOH intermediate is 
significantly smaller than when the substrate is 
absent or when the HPAH-C2-FMNred complex 
is mixed with a solution containing 4-
hydroxyphenylacetate and O2. Thus, it could 
be concluded that normally FMNred binds first, 
then O2 reacts to form the C(4a)-FMN-OOH, 
and finally, 4-hydroxyphenylacetic acid binds 
before hydroxylation takes place (22). For 
ActVA, with the substrate concentrations used 
in this study (0, 10 and 40 µM DHKred, Fig. 
1C, data not shown and Fig. 2A, respectively), 
no effect of DHKred on the kinetics of the 
reaction could be observed. However, because 
of the limited availability of the DHK substrate 
(it is not commercially available and has 
limited solubility), we could not determine if 
such an effect occurs with higher 
concentrations of DHKred, and therefore we do 
not know the preferred order of binding.  
In the presence of DHKred, the C(4a)-
FMN-OOH intermediate in the ActVA active 
site converted to a C(4a)-FMN-OH species, 
with a rate constant of 1.48 s-1. Formation of 
the C(4a)-FMN-OH species results from 
transfer of the distal oxygen of C(4a)-FMN-
OOH to the substrate, so that hydroxylation of 
DHKred to give DHKred-OH almost certainly 
occurred during that phase. In the subsequent 
step, the dehydration of the C(4a)-FMN-OH 
intermediate to form FMNox was observed at a 
rate of 0.16 s-1 (Fig. 2 and Scheme 2).  
The mechanism of DHKred hydroxylation 
catalyzed by ActVA with participation of the 
two reaction intermediates demonstrated in this 
study (Scheme 2) appears to be quite similar to 
that recently determined for the HPAH-C2 
component from A. baumannii (22), as well as 
that proposed for several single component 
hydroxylases (1, 18, 25, 28, 34, 35). These 
results reveal that, despite a rather low 
sequence identity between ActVA and HPAH-
C2 (23 % identities), the monooxygenase 
components in the two-component flavin-
dependent monooxygenase family use similar 
chemical mechanisms of hydroxylation.  
In the absence of the substrate, the C(4a)-
FMN-OOH intermediate forms rapidly (~3 x 
104 M-1 s-1) and is remarkably stable, as 
previously observed (17, 24), and thus slowly 
converts to FMNox (and probably H2O2) with a 
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half-life of ~1400 s. Formation of the 
hydroperoxide intermediate in the absence of 
substrate has also been observed for other 
members of the two-component flavin-
dependant monooxygenase family, such as 
styrene monooxygenase from Pseudomonas 
Putida S12 (37), the HPAH-C2 
monooxygenase from A. baumannii (22) and 
bacterial luciferase (38). The recently solved 
X-ray structure of the HPAH-C2 
monooxygenase from A. baumannii in 
complex with FMNred has revealed the 
presence of a cavity adjacent to the 
isoalloxazine ring of the flavin molecule that is 
appropriate for harbouring the oxygen atoms of 
the C(4a)-FMN-OOH intermediate (39). It was 
proposed that this cavity provides a solvent-
free environment that prevents rapid 
breakdown of the peroxide intermediate, thus 
accounting for its stability. In ActVA, one 
might expect an even more sequestered 
environment around the C(4a)-position of the 
flavin, because the C(4a)-FMN-OOH 
intermediate is about 75-fold more stable than 
in HPAH-C2 (half-life of 1400 s for ActVA 
and 18 s for HPAH-C2, this work and (22)). A 
sequence alignment between these two 
proteins shows that in HPAH-C2 the amino-
acid residues involved in the formation of the 
cavity near the C(4a)-position of the flavin are 
not totally conserved in ActVA. Presumably, 
these differences are responsible for the 
variations in stability of the peroxide 
intermediates.  
Because in two-component FMN-
dependent monooxygenases the reduction of 
the flavin takes place in a protein separate from 
the monooxygenase, FMNred must be 
transferred from the reductase to the 
monooxygenase in the presence of O2 without 
being oxidized unproductively. This represents 
a rather challenging process. Autooxidation of 
FMNred can be toxic to the cell because it 
produces the harmful O2•- and H2O2 species, 
and in addition, is wasteful of reducing 
equivalents by effectively decoupling the 
reduction of the flavin by NADH and the 
hydroxylation reaction. We have previously 
shown that in the case of the ActVA-ActVB 
system such decoupling does not occur to any 
measurable extent (17, 24), but the mechanism 
by which it is avoided was not documented. 
The results of the present study now provide 
some insight into this mechanism.  
i) First, we showed that ActVA binds free 
FMNred rapidly enough to prevent 
autooxidation of free FMNred. Bruice and 
colleagues have determined that the initial rate 
of reaction of O2 with free FMNred occurs at 
250 M-1 s-1 (40). Thus, in the presence of 200 
µM O2, this initial rate should be 0.05 s-1 and, 
even considering the ensuing autocatalytic 
oxidation process known for such reactions 
(28, 32, 40),
 
very little net oxidation of free 
FMNred will occur within the first 100 ms (27). 
The formation of the C(4a)-FMN-OOH 
intermediate (Fig. 1C) occurs at a rate of 5.9 s-1 
(t1/2 ~100 ms) whether FMNred is premixed 
with ActVA before or after mixing with O2. 
Because the binding of FMNred to ActVA does 
not limit the rate of formation of the rate of 
formation of the C(4a)-FMN-OOH, binding 
must occur at a rate ≥ 60 s-1 (t1/2 ≤ 10 ms), and 
thus will be complete before any appreciable 
autooxidation of flavin happens.  
This fast binding of FMNred to ActVA 
represents one of the key catalytic features of 
these systems where reduction of the flavin 
and activation of O2 occur in two different 
polypeptides. In addition to avoid uncoupling 
reactions during FMNred transfer, this fast 
binding of FMNred to ActVA also allows the 
rationalization of why the formation of a 
complex between the reductase and the 
monooxygenase is not required for efficient 
oxygenation reactions.     
ii) Second, we demonstrated that 
dissociation of NAD+ from ActVB limits the 
release and transfer of FMNred from the 
reductase ActVB to the monooxygenase ActVA. 
We showed that the dissociation of FMNred 
from ActVB is tightly regulated by NAD+, 
which must dissociate before FMNred can be 
released in the rate limiting step. A stable C–T 
complex between FMNred and NAD+ within the 
active site of ActVB limits the dissociation rate 
of NAD+. Accordingly, when the kinetics of 
the FMNred transfer between ActVB and 
ActVA was studied in the presence of 
increasing amounts of NAD+, a strong 
inhibition of the transfer of FMNred to ActVA 
was observed. An IC50 for NAD+ of 40 µM  
was determined, and the inhibition of the 
FMNred transfer was almost complete in the 
presence of 1 mM NAD+. Therefore in S. 
coelicolor, ActVB, the reductase component 
can act as a regulatory component of the 
monooxygenase activity by controlling the 
transfer of the FMNred cofactor to the 
monooxygenase.  
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Earlier steady-state kinetics studies 
showing that during ActVB catalysis, after the 
reduction of FMNox by NADH via hydride 
transfer, the NAD+ product is released before 
FMNred from the active site, in an ordered 
sequential mechanism (14). This confirms the 
notion that FMNred cannot dissociate from the 
ActVB active site when NAD+ is bound. Then, 
according to Le Chatelier’s principle, an 
increase of NAD+ concentration is likely to 
promote the formation of 
ActVB·FMNred·NAD+ complex and thereby 
prevent the release of free FMNred. This is 
consistent with the experiments presented 
above showing strong inhibition of the transfer 
of FMNred from ActVB to ActVA by NAD+.  
Control of the monooxygenase activity by 
NAD+ is unprecedented in the two-component 
flavin dependent monooxygenase family. 
However, in most studies, high concentrations 
of NAD+ were not present in reaction mixtures. 
Furthermore, few systems share with ActVB 
the observable rather stable flavinred·NAD+ 
charge-transfer complex. PheA2, the reductase 
of a two-component phenol hydroxylase from 
Bacillus thermoglucosidasius, is one such 
example (3), and it is possible that similar 
control of the activity by NAD+ also occurs in 
that case. Crystal structures show that NAD+ 
binds directly over the FADred in a position that 
is ideal for charge-transfer interactions (41). 
Recently, it was proposed that the activity of 
the monooxygenase component in the A. 
baumannii system was limited by the transfer 
of FMNred from the reductase, HPAH-C1, to 
the monooxygenase, HPAH-C2 (27). 
Furthermore, HPA, the monooxygenase 
substrate, was shown to function as an effector 
of HPAH-C1 for both FMN reduction and 
FMNred release (19, 27). Thus, as in the case of 
the ActVA-ActVB system, HPAH-C1, the 
reductase component, is likely to regulate the 
overall monooxygenase activity. However, in 
that case the effector is the substrate of the 
monooxygenase, HPA, whereas in ActVA-
ActVB system it is NAD+, the product of the 
reductase. 
Interestingly, it was also previously 
suggested that the oxygenases of the ActVA-
ActVB system (24) and the 4-
hydroxyphenylacetate hydroxylase (42) 
systems could be endowed with a regulatory 
function with respect to their reductases. In the 
absence of substrate, ActVA, traps free FMNred 
and converts it to a stable C(4a)-FMN-OOH 
intermediate. The consequence is that the 
cellular content of free FMN can become 
depleted, resulting in a shut-down of the 
reductase component activity. As highlighted 
by this work, the regulatory role of ActVB that 
is dependent on the intracellular concentration 
of NAD+ adds another important piece to the 
puzzle of the dynamic regulation of the 
ActVA-ActVB monooxygenase activity in a 
cellular context. It might allow coordination of 
the production of the DHKred-OH (and 
consequently the formation of the 
actinorhodin) to the energetic state of the cell, 
as determined by the NADH/NAD+ ratio. 
When this ratio is low in cells depleted of 
NADH, the FMNred would remain bound to the 
reductase component, preventing further 
oxidation of NADH and leading to the arrest of 
the hydroxylase activity. 
It therefore seems that for the two-
component monooxygenase systems there is a 
mutual regulation mechanism allowing the 
interpretation of different cellular signals for 
rapidly tuning the activities of each partner 
according to the demand and the status of the 
cell. In the case of the ActVA-ActVB system, 
ActVA could be perceived as the sensor of the 
intracellular concentration of DHK, whereas 
ActVB could be a sensor of the cellular 
energetic level indicated the NADH/NAD+ 
ratio.  
Finally, the results on the two-component 
flavin-dependent systems from A. baumannii 
(27) and S. coelicolor (17, 24 and this work) 
reveal that free diffusion of FMNred between 
two components in the presence of O2 can be 
very efficient for supporting monooxygenation 
reactions. It is clear that single component 
flavin-dependent monooxygenases can 
coordinate and carry out both reduction of the 
flavin and hydroxylation of substrates. 
Therefore, the advantage of a system using 
separate reductases and a monooxygenases 
might be questioned. Because flavin reduction 
and oxygen-dependent reactions have very 
different requirements that are difficult to fulfil 
with a single polypeptide, dividing the tasks by 
using two different enzymes is a reasonable 
strategy to alleviate this challenge. In the case 
of the single component flavoprotein 
hydroxylases, coordinated dynamics between 
two different conformations that effectively 
provides two “active sites” has been shown to 
be important for dealing with this challenge (1, 
18). This coordination is usually linked to the 
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substrate of the enzyme, so that adaptation to 
new substrates to trigger this dynamic dance of 
catalysis can be quite involved and 
complicated. Therefore, the two-component 
monooxygenase organization might represent 
an evolutionary advantage for quickly adapting 
to the metabolism of new substrates. The 
reductase and the monooxygenase 
polypeptides can acquire new complementary 
properties individually without modifying the 
structural requirements of the other 
component. This strategy more readily allows 
for variations to adapt to the hydroxylation of a 
broad range of substrates, as well as to 
different regulatory profiles. As pointed out 
above, even though the hydroxylation reactions 
occur with similar reaction mechanisms, the 
regulatory processes of the monooxygenase 
activity at the level of the reductase component 
in the case of the A. baumannii and S. 
coelicolor appear to be very different. 
Although such regulatory processes have not 
yet been explored for other two-component 
flavin monooxygenase systems, one might 
expect to find similar as well as new regulatory 
schemes for other systems. Consistent with this 
notion is the realization that two-component 
systems are continually being shown to be 
involved in the oxidation of an ever broader 
range of substrates.  
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FIGURE LEGENDS 
 
Figure 1. Reaction of ActVA·FMNred with O2 at pH 7.4, 4°C. A solution containing ActVA (50 µM) 
and FMNred (20 µM) in anaerobic 50 mM Tris-HCl buffer, was mixed in the stopped-flow instrument 
with an equal volume of oxygenated 50 mM Tris-HCl buffer, (O2 was 595 µM after mixing). A. UV-
visible spectra of the mixture (from the bottom to the top at 450 nm) recorded before and 5, 62, 180, 
300, 480, 660, 930, 1200, 1860, 2400, and 4320 s after mixing. B. Same protocol, but performed in the 
presence of various concentrations of O2 (60, 125, 299 and 595 µM after mixing). The absorbance 
traces at 386 nm as a function of time (dotted lines) are shown for each O2 concentration. Solid lines 
are fits to a single exponential model. (♦) is the absorbance trace at 445 nm in the presence of 595 µM 
O2, indicating the appearance of oxidized FMN. C. Plot of the pseudo first-order rate constants 
determined from the traces recorded at 386 nm shown in Fig. 1B as a function of O2 concentration. A 
second-order rate constant of 2.97 ± 0.06 104 M-1 s-1 for the formation of the ActVA·C(4a)-FMN-OOH 
species was calculated from the slope of the straight line. 
 
Figure 2. Reaction of the ActVA·FMNred complex with DHKred and O2. An anaerobic solution 
containing ActVA (50 µM), FMNox (20 µM), DHKox (80 µM), in 50 mM Tris-HCl buffer, pH 7.4, 
containing 10 % glycerol, was incubated for 20 minutes in the dark in the presence of PCA (50 µM), 
PCD (0.12 unit.mL), EDTA (10 mM), and 5-deazaflavin (60 nM). The mixture was illuminated by 
white light until the FMN and DHK were fully reduced (5-10 s), and then was mixed at 4°C in the 
stopped-flow instrument with an equal volume of the same buffer containing oxygen (595 µM O2). A. 
Traces of fluorescence (λexc=390 nm and λem> 530 nm) () and of absorbance at 365 (), 445 () 
and 520 nm (∇) vs. time (dotted lines). The four reaction phases are demarcated by dashed vertical 
lines. The dependence of each individual phase on oxygen is indicated at the top of the figure. Solid 
lines are fits for multi-exponential models, with k1 = 3.96 ± 0.05 x 104 M-1 s-1, k2 = 1.48 ± 0.15 s-1, k3 = 
0.25 ± 0.03 s-1 for the 365 nm trace, k3 = 0.16 ± 0.02 s-1 and k4 = 0.013 ± 0.002 s-1 for the 445 and 520 
nm traces and k2 = 1.48 ± 0.15 s-1, k3 = 0.16 ± 0.02 s-1, and k4 = 0.013 ± 0.002 s-1 for the  fluorescence 
trace. For the sake of clarity, all the traces are shifted to be zero intensity at 5 ms. B. Same protocol, 
but monitored with a diode array spectrophotometer. Spectra shown are recorded vs. anaerobic buffer 
(), and at 150 ms (), 2 s (), 200 s () after the addition of O2.  
 
Figure 3. FMNred transfer from ActVB to ActVA and formation of C(4a)-FMN-OOH. An anaerobic 
solution containing ActVB (85 µM), NAD+ (20 µM), FMNred  (20 µM), PCA (50 µM), and PCD (0.12 
unit.mL) was mixed in the stopped-flow instrument with an equal volume of oxygenated buffer 
containing ActVA (45 µM) and O2 (600 µM) at 4°C. Both solutions were in 50 mM Tris-HCl buffer, 
pH 7.4, containing 10 % glycerol. Concentrations given are those before mixing. A. UV-visible 
difference spectra of the mixture (spectrum at a given time minus the initial spectrum) recorded from 7 
ms to 1.5 s with a diode array spectrophotometer. The arrows indicate the direction of spectral 
evolution as a function of time. B. Absorbance traces (solid line) at 386 nm and 700 nm as a function 
of time. The smooth lines are fits to a single exponential model. Rate constants: k386nm = 4.6 ± 0.1 s-1 
and k700nm = 5.0 ± 0.4 s-1 were determined. 
 
Figure 4. Inhibition of FMNred transfer from ActVB to HPAH-C2 by NAD+. An anaerobic buffered 
solution containing ActVB (235 µM), NAD+ (40 µM), FMNred (40 µM), PCA (50 µM), PCD (0.12 
unit.mL), was first mixed with an equal volume of the same buffer containing various concentrations 
of free NAD+ (0 to 5000 µM). After 5 s this solution was mixed with an equal volume of the same 
buffer solution containing HPAH-C2 (50 µM) and O2 (255 µM). All concentrations given are those 
before mixing. The buffer used was 50 mM Tris-HCl, pH 7.4, containing 10 % glycerol, 4°C. The 
absorbance traces at 700 nm (A) and 386 nm (B), for each concentration of NAD+ (10, 40, 125, 325, 
625 and 1250 µM, concentrations after the second mix) are plotted as a function of time. The solid and 
smooth lines are fits for a single exponential model. C. The rate constants kobs 386 nm (○) and kobs 700 nm 
() obtained from Figs. 4A and 4B are plotted as a function of NAD+ concentration. The concentration 
of NAD+ required to inhibit the rate of FMNred transfer from ActVB to HPAH-C2 by 50 % is 40 µM.  
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Table 1. Rate constants determined from multi-exponential fits for the 365, 445, and 520 nm 
absorbance and fluorescence traces of Fig. 2A. The k1 (M-1 s-1) value is directly proportional to O2 
concentration, whereas k2, k3, and k4 (s-1) values are independent of O2 concentration. 
 
 
Trace k1 k2 k3 k4 
365 nm  3.96 ± 0.05 x 104 M-1 s-1 1.48 ± 0.15 s-1 0.25 ± 0.03 s-1 / 
445 nm / / 0.16 ± 0.02 s-1 0.013 ± 0.002 s-1 
520 nm / / 0.16 ± 0.02 s-1 0.013 ± 0.002 s-1 
Fluorescence at 530 nm / 1.48 ± 0.15 s-1 0.16 ± 0.02 s-1 0.013 ± 0.002 s-1 
 
 
 
 
Table 2. Reactions of free FMNred and ActVB·FMNred·NAD+ with ActVA, HPAH-C2, DCPIP, and 
menadione. Anaerobic solutions containing either ActVB (85 µM), NAD+ (20 µM) and FMNred  (20 
µM) or solely FMNred (20 µM), as well as PCA (25 µM), and PCD (0.12 unit. mL-1) in 50 mM Tris-
HCl buffer, pH 7.4, containing 10 % glycerol, were mixed with an equal volume of the same buffer 
containing either ActVA (45 µM) and O2 (600 µM), HPAH-C2 from Acinetobacter baumannii (45 
µM), and O2 (600 µM), oxidized DCPIP (20 µM), or menadione (40 µM). All reactions were carried 
out at 4°C and the concentrations given are those after mixing. The absorbance traces at 386 and 700 
nm were recorded as a function of time (as in Fig. 3) and were fit with a single exponential model. The 
rate constants (s-1) obtained from the traces at 386 (a), 450 (b) and 700 nm (c) are given below.  
 
 
 ActVA + O2 HPAH-C2 + O2 ActVA, no O2 DCPIP Menadione 
Free FMNred 10.6 ± 0.1a 330a, (22) / > 300b > 300b 
ActVB·FMNred·NAD+ 
4.6 ± 0.1a  
5.0 ± 0.4c 
4.7 ± 0.1a  
3.8 ± 0.1c 6.6 ± 0.9
c
 
6.2 ± 0.1b 
6.5 ± 0.1c 
6.1 ± 0.1b  
6.3 ± 0.1c   
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Scheme 1. Hydroxylation reaction catalyzed by the two-component ActVA-ActVB system from Streptomyces 
coelicolor. The reductase ActVB provides FMNred to the monooxygenase ActVA. The ActVA substrate (DHKred), is 
the dihydroquinone form of dihydrokalafungin (DHKox). Formation of Actinorhodin requires an additional DHKred-
OH dimerization step that has not been characterized (24). 
 
 
 
 
 
 
 
 
Scheme 2. Minimal catalytic scheme of the ActVA-catalyzed hydroxylation of DHKred.  
 
 
 
 
 
 
 
 
Scheme 3. Scheme of FMNred transfer from reductase, ActVB, to the hydroxylase, ActVA. NAD+ 
controls the release of FMNred from ActVB and therefore acts as a regulator of the hydroxylase 
activity.  
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